Garetosmab targets Activin A, a key driver of ectopic bone formation in FOP, with preclinical evidence that pathway ...

In a new study published in Bone Research, a team of researchers from Johns Hopkins University and colleagues, using a combination of lineage tracing and single-cell RNA sequencing (scRNA-seq), has ...

Pasatru demonstrated strong efficacy in a Phase III trial, helping patients reduce lesions and flare-ups.

Heterotopic ossification (HO) refers to the pathological formation of mature bone in soft tissues, most frequently following trauma, surgery or neurological injury, but also arising in rare genetic ...

Musculoskeletal disorders are a primary cause of disability worldwide, especially in aging societies like Japan. As individuals age, reductions in muscle mass and physical activity weaken the body's ...

The FDA approved a novel therapy for reducing the formation of heterotopic ossification lesions and flare-ups for adults with ...

Proposed model for Regulation of BMP Activity by DDR2. After binding collagen, DDR2 alone or together with collagen-binding β1 integrins stabilizes YAP/TAZ nuclear accumulation. This is accomplished ...

Ultra-rare fibrodysplasia ossificans progressiva now has its second approved drug ...

The approval was supported by data from the phase 3 OPTIMA trial, which enrolled 63 adults with FOP confirmed by an ACVR1 FOP ...

Bone regeneration research has taken a significant leap forward with the discovery of a crucial mechanism that could transform treatments for bone disorders. Scientists have identified how Discoidin ...

image: Tppp3+ tendon sheath progenitors expand at the heterotopic ossification (HO) induction site after Achilles tendon injury. a Schematic representation of HO induction, including complete Achilles ...